Victims of 23andMe data breach to get $47m payout, judge rules
23andMe compiles genetic profiles of people through DNA testing kits, but it was heavily criticised after a 2023 hack.


Glideslope AI-powered market news
No market stories in the last 7 days. The latest coverage is below.

No scored stories in the last 7 days.
| Day | Mood | Stories |
|---|---|---|
| Sat, Oct 10 | — | 0 |
| Fri, Oct 9 | — | 0 |
| Thu, Oct 8 | — | 0 |
| Wed, Oct 7 | — | 0 |
| Tue, Oct 6 | — | 0 |
| Mon, Oct 5 | — | 0 |
| Sun, Oct 4 | — | 0 |
| Sat, Oct 3 | — | 0 |
23andMe compiles genetic profiles of people through DNA testing kits, but it was heavily criticised after a 2023 hack.

Attorney General Rob Bonta alleges the company lied about the breach's severity.

The DNA data of millions of people who used 23andMe's services won't be sold to a pharmaceutical company. A bankruptcy judge greenlighted the sale of the remna…
Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, d…
The fine comes as the DNA testing firm, which filed for bankruptcy in March, is set to be sold to a new owner.

Anne Wojcicki to buy back 23andMe and its data for $305 million

23andMe filed for bankruptcy in March, seeking to sell its business at auction after a decline in consumer demand and a 2023 data breachthat exposed sensitive…

Bankrupt 23andMe is facing a lawsuit over its plans to sell customer genetic information.

The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the District of Columbia oppose selling t…

State attorneys general are seeking a ruling in 23andMe's bankruptcy that the DNA-testing firm needs explicit consent from customers before transferring their…
States argue that biological samples, DNA data, health-related traits and medical records are too sensitive to be sold without each person's express, informed…
23andMe is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, casting doubt on its deal with Re…

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

The pharmaceutical giant plans to continue offering 23andMe's DNA testing service and pledged to adopt its privacy practices to protect customer data.
It will acquire genetic data of more than 15 million customers - raising privacy concerns from individuals who had willingly handed over the samples to complet…

It said new buyers Regeneron had committed to protect user data as part of the deal.

Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's privacy policies.

Regeneron said it will continue uninterrupted service of 23andMe's consumer genome services after its purchase closes as expected in the third quarter of this…
Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, the companies said on Monday.

Reporter Alexi Horowitz-Ghazi's Aunt Vovi signed up for 23andMe back in 2017, hoping to learn more about the genetic makeup of her ancestors. Vovi was one of o…
The House Committee on Energy and Commerce is investigating 23andMe's decision to file for bankruptcy

Any purchaser of 23andMe assets should agree to be bound by the company's existing privacy policy, FTC Chairman Andrew Ferguson said.

Genetic testing company 23andMe's bankruptcy has led to a new consumer privacy issue: what happens to the DNA of millions of Americans when it goes on sale?

The bankruptcy filing of 23andMe has sparked the potential for a sale that could be used to solve cold cases with the use of genetic testing.

After 23andMe announced that it's headed to bankruptcy court, it's unclear what happens to the mass of sensitive genetic data that it holds.
NPR's Juana Summers talks with John Verdi, senior vice president for policy at the Future of Privacy Forum, about 23andMe's bankruptcy filing and what a potent…
Now that 23andMe has filed for bankruptcy, another company could take control of its genetic database.

The company saw its DNA data as an engine that would revolutionize drug discovery and medical care, but it never found a sustainable business model.
Privacy experts are urging consumers to protect their 23andMe data now that it has declared bankruptcy. Here's how to delete yours.

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE